|
1
|
Humbert M, Sitbon O and Simonneau G:
Treatment of pulmonary arterial hypertension. N Engl J Med.
351:1425–1436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuder RM: Pathology of pulmonary arterial
hypertension. Semin Respir Crit Care Med. 30:376–385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wright JL, Farmer SG and Churg A: A
neutrophil elastase inhibitor reduces cigarette smoke-induced
remodelling of lung vessels. Eur Respir J. 22:77–81. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Seimetz M, Parajuli N, Pichl A, et al:
Inducible NOS inhibition reverses tobacco-smoke-induced emphysema
and pulmonary hypertension in mice. Cell. 147:293–305. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ribatti D, Vacca A, Rusnati M and Presta
M: The discovery of basic fibroblast growth factor/fibroblast
growth factor-2 and its role in haematological malignancies.
Cytokine Growth Factor Rev. 18:327–334. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang JH, Han KY and Azar DT: Wound
healing fibroblasts modulate corneal angiogenic privilege:
interplay of basic fibroblast growth factor and matrix
metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol.
54:199–205. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Handayani R, Rice L, Cui YH, et al: Soy
isoflavones alter expression of genes associated with cancer
progression, including interleukin-8, in androgen-independent PC-3
human prostate cancer cells. J Nutr. 136:75–82. 2006.
|
|
8
|
Liu Y and Templeton DM: Iron-loaded
cardiac myocytes stimulate cardiac myofibroblast DNA synthesis. Mol
Cell Biochem. 281:77–85. 2006. View Article : Google Scholar
|
|
9
|
Wang R, Xu YJ, Liu XS, Zeng DX and Xiang
M: Knockdown of connective tissue growth factor by plasmid-based
short hairpin RNA prevented pulmonary vascular remodeling in
cigarette smoke-exposed rats. Arch Biochem Biophys. 508:93–100.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Carraway MS, Ghio AJ, Suliman HB, Carter
JD, Whorton AR and Piantadosi CA: Carbon monoxide promotes hypoxic
pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol.
282:L693–L702. 2002.PubMed/NCBI
|
|
11
|
Quinlan TR, Li D, Laubach VE, Shesely EG,
Zhou N and Johns RA: eNOS-deficient mice show reduced pulmonary
vascular proliferation and remodeling to chronic hypoxia. Am J
Physiol Lung Cell Mol Physiol. 279:L641–L650. 2000.PubMed/NCBI
|
|
12
|
Mandegar M, Fung YCB, Huang W, Remillard
CV, Rubin LJ and Yuan JXJ: Cellular and molecular mechanisms of
pulmonary vascular remodeling: role in the development of pulmonary
hypertension. Microvasc Res. 68:75–103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pidgeon GP, Tamosiuniene R, Chen G, et al:
Intravascular thrombosis after hypoxia-induced pulmonary
hypertension - Regulation by cyclooxygenase-2. Circulation.
110:2701–2707. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wright JL, Levy RD and Churg A: Pulmonary
hypertension in chronic obstructive pulmonary disease: current
theories of pathogenesis and their implications for treatment.
Thorax. 60:605–609. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamato H, Sun JP, Churg A and Wright JL:
Guinea pig pulmonary hypertension caused by cigarette smoke cannot
be explained by capillary bed destruction. J Appl Physiol.
82:1644–1653. 1997.PubMed/NCBI
|
|
16
|
Wright JL, Tai H and Churg A: Vasoactive
mediators and pulmonary hypertension after cigarette smoke exposure
in the guinea pig. J Appl Physiol. 100:672–678. 2006. View Article : Google Scholar
|
|
17
|
Wang R, Xu YJ, Liu XS, Zeng DX and Xiang
M: CCN2 promotes cigarette smoke-induced proliferation of rat
pulmonary artery smooth muscle cells through upregulating cyclin D1
expression. J Cell Biochem. 113:349–359. 2012. View Article : Google Scholar
|
|
18
|
Friehs I, Moran AM, Stamm C, et al:
Promoting angiogenesis protects severely hypertrophied hearts from
ischemic injury. Ann Thorac Surg. 77:2004–2011. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Detillieux KA, Sheikh F, Kardami E and
Cattini PA: Biological activities of fibroblast growth factor-2 in
the adult myocardium. Cardiovasc Res. 57:8–19. 2003. View Article : Google Scholar
|
|
20
|
Garbern JC, Minami E, Stayton PS and Murry
CE: Delivery of basic fibroblast growth factor with a
pH-responsive, injectable hydrogel to improve angiogenesis in
infarcted myocardium. Biomaterials. 32:2407–2416. 2011. View Article : Google Scholar :
|
|
21
|
Benisty JI, McLaughlin VV, Landzberg MJ,
et al: Elevated basic fibroblast growth factor levels in patients
with pulmonary arterial hypertension. Chest. 126:1255–1261. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Arcot SS, Fagerland JA, Lipke DW,
Gillespie MN and Olson JW: Basic fibroblast growth factor
alterations during development of monocrotaline-induced pulmonary
hypertension in rats. Growth Factors. 12:121–130. 1995. View Article : Google Scholar : PubMed/NCBI
|
